The levels of p-Akt in human serum were examined using a clinical sample set, which included serum samples from eight normal control subjects, eight patients with NSCLC without CYP1A1 overediting, and eight patients with NSCLC with CYP1A1 overediting for confirmation. Here, AKT1 is linked to non-small cell lung carcinoma.